Kevin Norrett
CIK 1819690 · Chief Business Officer · last filed 2026-05-18
Kevin Norrett is a Chief Business Officer who has filed 15 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for SLNO, was dated May 18, 2026. Across all open-market trades the lifetime net is −$61.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $425.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$425.6K
3
15
-$61.7K
Holdings By Company
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | SLNO | Disp (D) | −17,786 | $0 | EDGAR |
| 2026-01-23 | SLNO | Grant (A) | +3,500 | $0 | EDGAR |
| 2025-11-19 | SLNO | Mixed | +14,286 | $0 | EDGAR |
| 2025-02-07 | CDXS | Grant (A) | +26,875 | $0 | EDGAR |
| 2024-01-02 | CDXS | Grant (A) | +52,350 | $0 | EDGAR |
| 2023-09-12 | CDXS | Buy (P) | +9,000 | $15.5K | EDGAR |
| 2023-03-09 | CDXS | Mixed | +66,602 | -$77.2K | EDGAR |
| 2023-02-21 | CDXS | Grant (A) | +22,500 | $0 | EDGAR |
| 2022-10-05 | CDXS | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | — | $0 | EDGAR |